A review of pooled‐sample strategy: Does complexity lead to better performance?

ABSTRACT

The outbreak of coronavirus disease 2019 (COVID‐19, caused by SARS‐Cov‐2) is a big challenge for global health systems and the economy. Rapid and accurate tests are crucial at early stages of this pandemic. Reverse transcription‐quantitative real‐time polymerase chain reaction is the current gold standard method for detection of SARS‐Cov‐2. It is impractical and costly to test individuals in large‐scale population screens, especially in low‐ and middle‐income countries due to their shortage of nucleic acid testing reagents and skilled staff. Accordingly, sample pooling, such as for blood screening for syphilis, is now widely applied to COVID‐19. In this paper, we survey and review several different pooled‐sample testing strategies, based on their group size, prevalence, testing number, and sensitivity, and we discuss their efficiency in terms of reducing cost and saving time while ensuring sensitivity.